Invention Grant
- Patent Title: Method of inducing an immune response against HIV employing HIV immunogens, adenoviral vectors encoding said immunogens, and adjuvant
-
Application No.: US13744867Application Date: 2013-01-18
-
Publication No.: US09717788B2Publication Date: 2017-08-01
- Inventor: Gerald Hermann Voss
- Applicant: GlaxoSmithKline Biologicals, s.a.
- Applicant Address: BE
- Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee Address: BE
- Agent Eric Kron
- Main IPC: A61K39/21
- IPC: A61K39/21 ; A61K39/015 ; A61K39/12 ; A61K39/00

Abstract:
The present invention relates to, inter alia, a method of raising an immune response against a pathogen which comprises administering (i) one or more first immunogenic polypeptides derived from said pathogen; (ii) one or more adenoviral vectors comprising one or more heterologous polynucleotides encoding one or more second immunogenic polypeptides derived from said pathogen; and (iii) an adjuvant; wherein the one or more first immunogenic polypeptides, the one or more adenoviral vectors and the adjuvant are administered concomitantly. The invention also relates to vaccines, pharmaceutical compositions, kits and uses employing said polypeptides, adenoviral vectors and adjuvants.
Public/Granted literature
- US20140205652A1 NOVEL METHOD AND COMPOSITIONS Public/Granted day:2014-07-24
Information query